Is maxillomandibular advancement associated with comorbidity reduction in patients with obstructive sleep apnea?

In patients with documented obstructive sleep apnea (OSA) who experience reduction in AHI and self-reported symptoms after maxillomandibular advancement with genial tubercle advancement (MMA/GTA), is there also a change in the medical comorbidity profile a minimum of two years postoperatively? We are assessing for changes in: the quantity of medical diagnoses; the quantity of prescription medications; and the average weight and BMI.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Bpu5lt